In search of a pediatric cardiac surgeon’s ‘Holy Grail’: the ideal pulmonary conduit

References

• Schultz JM, Shen I, Ungerleider RM. Right ventricle-pulmonary artery conduits. In: Sabiston & Spencer Surgery of the Chest. Sellke FW, del Nido PJ, Swanson SJ (Eds). Elsevier Saunders, Philadelphia, PA, USA 2049–2062 (2005).
   Google Scholar
• Shaddy RE, Hawkins JA. Immunology and failure of valved allografts in children. Ann. Thorac. Surg.74, 1271–1275 (2002).
   PubMed Web of Science ®Google Scholar
• Christenson JT, Vala D, Sierra J, Beghetti M, Kalangos A. Blood group incompatibility and acclerated homograft fibrocalcifications. J. Thorac. Cardiovasc. Surg.127, 242–250 (2004).
   PubMedGoogle Scholar
• Stark J, Bull C, Stajevic M, Jothi M, Elliot M, de Leval M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J. Thorac. Cardiovasc. Surg.115, 506–516 (1998).
   PubMed Web of Science ®Google Scholar
• Meyns B, Jashari R, Gewillig M et al. Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first. Eur. J. Cardiothorac. Surg.28, 211–216 (2005).
   PubMed Web of Science ®Google Scholar
• Caldarone CA, McCrindle BW, Van Arsdell GSV et al. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J. Thorac. Cardiovasc. Surg.120, 1022–1031 (2000).
   PubMed Web of Science ®Google Scholar
• Dearani JA, Danielson JK, Puga FJ et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann. Thorac. Surg.75, 399–411 (2003).
   PubMed Web of Science ®Google Scholar
• Forbess JM, Shah AS, St. Louis JD, Jaggers JJ, Ungerleider RM. Cryopreserved homografts in the pulmonary position: determinants of durability. Ann. Thorac. Surg.71, 54–59 (2001).
   PubMed Web of Science ®Google Scholar
• Niwaya K, Knott-Craig CJ, Lane MM, Chandrasekharan K, Overholt ED, Elkins RC. Cryopreserved homograft valves in the pulmonary position: risk-analysis for intermediate-term failure. J. Thorac. Cardiovasc. Surg.117, 141–147 (1999).
   PubMed Web of Science ®Google Scholar
• Stark J. The use of valved conduits in pediatric cardiac surgery. Pediatr. Cardiol.19, 282–288 (1998).
   PubMed Web of Science ®Google Scholar
• Schorn K, Yankah AC, Alexi-Meskhishvili V, Weng Y, Lange PE, Hetzer R. Risk factors for early degeneration of allografts in pulmonary circulation. Eur. J. Cardiothorac. Surg.11, 62–69 (1997).
   PubMedGoogle Scholar
• Sinzobahamvya N, Wetter J, Blaschczok HC, Cho M, Brecher AM, Urban AE. The fate of small-diameter homografts in the pulmonary position. Ann. Thorac. Surg.72, 2070–2076 (2001).
   PubMed Web of Science ®Google Scholar
• da Costa FDA, Dohmen PM, Duarte D et al. Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. Eur. J. Cardiothorac. Surg.27, 572–578 (2005).
   PubMedGoogle Scholar
• Hawkins JA, Hillman ND, Lambert LM et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparision with standard cryopreserved allografts. J. Thorac. Cardiovasc. Surg.126, 247–252 (2003).
   PubMed Web of Science ®Google Scholar
• Tavakkol Z, Gelehrter S, Goldberg CS, Bove EL, Devaney EJ, Ohye RG. Superior durability of Synergraft pulmonary allografts compared with standard cryopreserved allografts. Ann. Thorac. Surg.80, 1610–1614 (2005).
   PubMedGoogle Scholar
• Karamlou T, Ungerleider RM, Alsoufi B et al. Oversizing pulmonary homograft conduits does not significantly decrease allograft failure in children. Eur. J. Cardiothorac. Surg.27, 548–553 (2005).
   PubMedGoogle Scholar
• Levine AJ, Miller PA, Stumper OS et al. Early results of right-ventricular-pulmonary artery conduits in patients under 1 year of age. Eur. J. Cardiothorac. Surg.19, 122–126 (2001).
   PubMedGoogle Scholar
• Dittrich S, Alexi-Meskishvili VV, Yankah AC et al. Comparision of porcine xenografts and homografts for pulmonary valve replacement in children. Ann. Thorac. Surg.70, 717–722 (2000).
   PubMed Web of Science ®Google Scholar
• Pearl JM, Cooper DS, Bove KE, Manning PB. Early failure of the Shelhigh pulmonary valve conduit in infants. Ann. Thorac. Surg.74, 542–549 (2002).
   PubMedGoogle Scholar
• Ishizaka T, Ohye RG, Goldberg CS et al. Premature failure of small-sized Shelhigh No-React porcine pulmonic valve conduit model NR-4000. Eur. J. Cardiothorac. Surg.23, 715–718 (2003).
   PubMed Web of Science ®Google Scholar
• Boudjemline Y, Beyler C, Bonnet D, Sidi D. Surprising outcome similarities between Contegra bovine jugular vein conduit and Shelhigh No-React porcine valve conduit: role of immunologic reaction. Eur. J. Cardiothorac. Surg.24, 850–851 (2003).
   PubMed Web of Science ®Google Scholar
• Marianeschi SM, Iacona GM, Seddio F et al. Shelhigh No-React porcine pulmonic valve conduit: a new alternative to the homograft. Ann. Thorac. Surg.71, 619–623 (2001).
   PubMed Web of Science ®Google Scholar
• Schreiber C, Bauernschmitt R, Augustin N et al. Implantation of a prosthesis mounted inside a self-expandable stent in the pulmonary valvar area without use of cardiopulmonary bypass. Ann. Thorac. Surg.81, e1–e3 (2006).
   PubMedGoogle Scholar
• Gober V, Berdat P, Pavlovic M, Pfammatter JP, Carrel TP. Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein. Ann. Thorac. Surg.79, 625–631 (2005).
   PubMed Web of Science ®Google Scholar
• Shebani OS, McGuirk S, Baghai M et al. Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure. Eur. J. Cardiothorac. Surg.29, 397–405 (2006).
   PubMed Web of Science ®Google Scholar
• Meyns B, Garsse LV, Boshoff D et al. The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis. J. Thorac. Cardiovasc. Surg.128, 834–840 (2004).
   PubMed Web of Science ®Google Scholar
• Tiete AR, Sachweh JS, Roemer U, Kozlik-Feldmann R, Reichart B, Daebritz SH. Right ventricular outflow tract reconstruction with the Contegra bovine jugular vein conduit: a word of caution. Ann. Thorac. Surg.77, 2151–2156 (2004).
   PubMed Web of Science ®Google Scholar
• Corno AF, Qanadli SD, Sekarski N et al. Bovine valved xenograft in pulmonary position: medium-term follow-up with excellent hemodynamics and freedom from calcification. Ann. Thorac. Surg.78, 1382–1388 (2004).
   PubMed Web of Science ®Google Scholar
• Dave HH, Kadner A, Berger F et al. Early results of the bovine jugular vein graft used for reconstruction of the right ventricular outflow tract. Ann. Thorac. Surg.79, 618–624 (2005).
   PubMed Web of Science ®Google Scholar
• Ando M, Imai Y, Takanashi Y, Hoshino S, Seo K, Terada M. Fate of trileaflet equine pericardial extracardiac conduit used for the correction of anomalies having pulmonic ventricle-pulmonary arterial discontinuity. Ann. Thorac. Surg.64, 154–158 (1997).
   PubMedGoogle Scholar
• Chard RB, Kang N, Andrews DR, Nunn GR. Use of the Medtronic Freestyle valve as a right ventricular to pulmonary artery conduit. Ann. Thorac. Surg.71, S361–S364 (2001).
   PubMedGoogle Scholar
• Novick WM, Anic D, Solf AL et al. Medtronic freestyle valve for right ventricular reconstruction in pediatric ross operations. Ann. Thorac. Surg.77, 1711–1716 (2004).
   PubMed Web of Science ®Google Scholar
• Kanter KR, Fyfe DA, Mahle WT, Forbess JM, Kirshbom PM. Results with the freestyle porcine aortic root for right ventricular outflow tract reconstruction in children. Ann. Thorac. Surg.76, 1889–1895 (2003).
   PubMedGoogle Scholar
• Aupecle B, Serraf A, Belli E et al. Intermediate follow-up of a composite stentless porcine valved conduit of bovine pericardium in the pulmonary circulation. Ann. Thorac. Surg.74, 127–132 (2002).
   PubMedGoogle Scholar
• Haas F, Schreiber C, Horer J, Kostolny M, Holper K, Lange R. Is there a role for mechanical valved conduits in the pulmonary position? Ann. Thorac. Surg.79, 1662–1667 (2005).
   PubMed Web of Science ®Google Scholar
• Bermudez CA, Dearani JA, Puga FJ et al. Late results of the peel operation for replacement of failing extracardiac conduits. Ann. Thorac. Surg.77, 881–888 (2004).
   PubMedGoogle Scholar
• Isomatsu Y, Shin’oka T, Aoki M et al. Establishing right ventricle-pulmonary artery continuity by autologous tissue: an alternative approach for prosthetic conduit repair. Ann. Thorac. Surg.78, 173–180 (2004).
   PubMedGoogle Scholar
• Nakae S, Kawada M, Kasahara S, Kuroyama N, Hiraishi S, Yoshimura H. Anterior pulmonary translocation without conduit for the repair of truncus arteriosus. Ann. Thorac. Surg.61, 990–992 (1996).
   PubMedGoogle Scholar
• Danton MHD, Barron DJ, Stumper O et al. Repair of truncus arteriosus: a considered approach to right ventricular outflow tract reconstruction. Eur. J. Cardiothorac. Surg.20, 95–104 (2001).
   PubMed Web of Science ®Google Scholar
• Quintessenza JA, Jacobs JP, Morell VO, Giroud JM, Boucek RJ. Initial experience with a bicuspid polytetrafluoroethylene pulmonary valve in 41 children and adults: a new option for right ventricular outflow tract reconstruction. Ann. Thorac. Surg.79, 924–931 (2005).
   PubMed Web of Science ®Google Scholar
• Robin J, Martinot S, Curtil A et al. Experimental right ventricle to pulmonary artery discontinuity: outcome of polyurethane valved conduits. J. Thorac. Cardiovasc. Surg.115, 898–903 (1998).
   PubMedGoogle Scholar
• Nikaidoh H. Aortic translocation and biventricular outflow tract reconstruction: a new surgical repair for transposition of great arteries associated with a ventricular septal defect and pulmonary stenosis. J. Thorac. Cardiovasc. Surg.88, 365–372 (1984).
   PubMedGoogle Scholar
• Morell VO, Jacobs JP, Quintessenza JA. Aortic translocation in the management of transposition of great arteries with ventricular septal defect and pulmonary stenosis: results and follow-up. Ann. Thorac. Surg.79, 2089–2093 (2005).
   PubMed Web of Science ®Google Scholar
• Bonhoeffer P, Boudjemline Y, Qureshi SA et al. Percutaneous insertion of the pulmonary valve. J. Am. Coll. Cardiol.39, 1664–1669 (2002).
   PubMed Web of Science ®Google Scholar
• Lutter G, Ardehali R, Cremer J, Bonhoeffer P. Percutaneous valve replacement: current state and future prospects. Ann. Thorac. Surg.78, 2199–2206 (2004).
   PubMedGoogle Scholar
• Zhou JQ, Corno AF, Huber CH, Tozzi P, von Segesser LK. Self-expandable valved stent of large size: off-bypass implantation in pulmonary position. Eur. J. Cardiothorac. Surg.28, 211–216 (2005).
   PubMedGoogle Scholar
• Attmann T, Jahnke T, Quaden R et al. Advances in experimental percutaneous pulmonary valve replacement. Ann. Thorac. Surg.80, 969–975 (2005).
   PubMedGoogle Scholar
• Hijazi ZM. Transcatheter valve replacement: a new era of percutaneous cardiac intervention begins. J. Am. Coll. Cardiol.43, 1088–1089 (2004).
   PubMedGoogle Scholar
• Fuchs JR, Nasseri BA, Vacanti JP. Tissue engineering: a 21st century solution to surgical reconstruction. Ann. Thorac. Surg.72, 577–591 (2001).
   PubMed Web of Science ®Google Scholar
• Leyh RG, Wilhelmi M, Rebe P et al. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann. Thorac. Surg.75, 1457–1463 (2003).
   PubMedGoogle Scholar
• Stock UA, Nagashima M, Khalil PN et al. Tissue-engineered valved conduits in the pulmonary circulation. J. Thorac. Cardiovasc. Surg.119, 732–740 (2000).
   PubMed Web of Science ®Google Scholar
• Hoerstrup SP, Kadner A, Breymann C et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann. Thorac. Surg.74, 46–52 (2002).
   PubMed Web of Science ®Google Scholar
• Juthier F, Vincentelli A, Gaudric J et al. Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor. J. Thorac. Cardiovasc. Surg.131, 843–852 (2006).
   PubMedGoogle Scholar
• Leyh RG, Wilhelmi M, Rebe P, Ciboutari S, Haverich A, Mertsching H. Tissue engineering of viable pulmonary arteries for surgical correction of congenital heart defects. Ann. Thorac. Surg.81, 1466–1471 (2006).
   PubMedGoogle Scholar
• Rieder E, Seebacher G, Kasimir MT et al. Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation111, 2792–2797 (2005).
   PubMed Web of Science ®Google Scholar
• Hoerstrup SP, Kadner A, Melnitchouk S et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation106, I143–I150 (2002).
   PubMed Web of Science ®Google Scholar